FDA Proposes Rule to Modernize Drug Manufacturing Registration

Proposed rule would streamline registration for advanced distributed manufacturers and increase visibility into foreign drug supply sources Proposed rule would streamline registration for advanced distributed manufacturers and increase visibility into foreign drug supply sources